Cookson Peirce & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,633
| Closed | -$267K | – | 277 |
|
|
2025
Q1 | $267K | Buy |
3,633
+249
| +7% | +$18.3K | 0.01% | 241 |
|
|
2024
Q4 | $222K | Sell |
3,384
-480,283
| -99% | -$31.5M | 0.01% | 254 |
|
|
2024
Q3 | $37.7M | Buy |
+483,667
| New | +$37.7M | 1.77% | 17 |
|
|
2023
Q3 | – | Sell |
-3,831
| Closed | -$274K | – | 206 |
|
|
2023
Q2 | $274K | Sell |
3,831
-121
| -3% | -$8.65K | 0.02% | 181 |
|
|
2023
Q1 | $274K | Hold |
3,952
| – | – | 0.02% | 181 |
|
|
2022
Q4 | $268K | Sell |
3,952
-507,559
| -99% | -$34.4M | 0.02% | 169 |
|
|
2022
Q3 | $28.1M | Buy |
511,511
+1,183
| +0.2% | +$64.9K | 1.98% | 14 |
|
|
2022
Q2 | $33.7M | Buy |
+510,328
| New | +$33.7M | 2.32% | 8 |
|
|
2021
Q4 | – | Sell |
-3,610
| Closed | -$217K | – | 207 |
|
|
2021
Q3 | $217K | Buy |
+3,610
| New | +$217K | 0.01% | 203 |
|
|
2020
Q4 | – | Sell |
-178,440
| Closed | -$9.78M | – | 157 |
|
|
2020
Q3 | $9.78M | Buy |
178,440
+55,144
| +45% | +$3.02M | 0.73% | 44 |
|
|
2020
Q2 | $6.52M | Sell |
123,296
-3,192
| -3% | -$169K | 0.61% | 47 |
|
|
2020
Q1 | $5.65M | Sell |
126,488
-217,620
| -63% | -$9.72M | 0.65% | 45 |
|
|
2019
Q4 | $17.2M | Sell |
344,108
-10,071
| -3% | -$502K | 1.51% | 26 |
|
|
2019
Q3 | $15.8M | Sell |
354,179
-9,950
| -3% | -$443K | 1.38% | 31 |
|
|
2019
Q2 | $15M | Buy |
364,129
+59
| +0% | +$2.44K | 1.26% | 33 |
|
|
2019
Q1 | $14.7M | Sell |
364,070
-1,680
| -0.5% | -$67.9K | 1.24% | 36 |
|
|
2018
Q4 | $13.9M | Buy |
+365,750
| New | +$13.9M | 1.34% | 32 |
|